Daiichi Sankyo (OTCMKTS:DSNKY) Trading Up 5.1% – Should You Buy?

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) rose 5.1% on Monday . The stock traded as high as $23.32 and last traded at $22.50. Approximately 94,533 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 255,678 shares. The stock had previously closed at $21.40.

Wall Street Analysts Forecast Growth

Separately, Zacks Research lowered Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Daiichi Sankyo presently has an average rating of “Moderate Buy”.

Daiichi Sankyo Stock Performance

The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 1.60. The company has a fifty day moving average of $24.03 and a two-hundred day moving average of $24.07. The stock has a market capitalization of $42.02 billion and a P/E ratio of 20.92.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.